Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |